Glatiramer Drugs Market, Global Outlook and Forecast 2022-2028

February 2022 | 73 pages | ID: GA6A353677A2EN
Market Monitor Global

Abstracts

Glatiramer is an immunomodulator medication currently used to treat multiple sclerosis.

This report contains market size and forecasts of Glatiramer Drugs in global, including the following market information:

Global Glatiramer Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Glatiramer Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Glatiramer Drugs companies in 2021 (%)

The global Glatiramer Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Brand Medicine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Glatiramer Drugs include Teva, NATCO Pharma, Mylan, Novartis and HYBIO, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glatiramer Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Glatiramer Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Glatiramer Drugs Market Segment Percentages, by Type, 2021 (%)

• Brand Medicine
• Generic Drug

Global Glatiramer Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Glatiramer Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Pharmacy
• Other

Global Glatiramer Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Glatiramer Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Glatiramer Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Glatiramer Drugs revenues share in global market, 2021 (%)

Key companies Glatiramer Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Glatiramer Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva
• NATCO Pharma
• Mylan
• Novartis
• HYBIO

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Glatiramer Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Glatiramer Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GLATIRAMER DRUGS OVERALL MARKET SIZE

2.1 Global Glatiramer Drugs Market Size: 2021 VS 2028
2.2 Global Glatiramer Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Glatiramer Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Glatiramer Drugs Players in Global Market
3.2 Top Global Glatiramer Drugs Companies Ranked by Revenue
3.3 Global Glatiramer Drugs Revenue by Companies
3.4 Global Glatiramer Drugs Sales by Companies
3.5 Global Glatiramer Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Glatiramer Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Glatiramer Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glatiramer Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Glatiramer Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Glatiramer Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Glatiramer Drugs Market Size Markets, 2021 & 2028
  4.1.2 Brand Medicine
  4.1.3 Generic Drug
4.2 By Type - Global Glatiramer Drugs Revenue & Forecasts
  4.2.1 By Type - Global Glatiramer Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Glatiramer Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Glatiramer Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Glatiramer Drugs Sales & Forecasts
  4.3.1 By Type - Global Glatiramer Drugs Sales, 2017-2022
  4.3.2 By Type - Global Glatiramer Drugs Sales, 2023-2028
  4.3.3 By Type - Global Glatiramer Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Glatiramer Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Glatiramer Drugs Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Pharmacy
  5.1.4 Other
5.2 By Application - Global Glatiramer Drugs Revenue & Forecasts
  5.2.1 By Application - Global Glatiramer Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Glatiramer Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Glatiramer Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Glatiramer Drugs Sales & Forecasts
  5.3.1 By Application - Global Glatiramer Drugs Sales, 2017-2022
  5.3.2 By Application - Global Glatiramer Drugs Sales, 2023-2028
  5.3.3 By Application - Global Glatiramer Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Glatiramer Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Glatiramer Drugs Market Size, 2021 & 2028
6.2 By Region - Global Glatiramer Drugs Revenue & Forecasts
  6.2.1 By Region - Global Glatiramer Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Glatiramer Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Glatiramer Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Glatiramer Drugs Sales & Forecasts
  6.3.1 By Region - Global Glatiramer Drugs Sales, 2017-2022
  6.3.2 By Region - Global Glatiramer Drugs Sales, 2023-2028
  6.3.3 By Region - Global Glatiramer Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Glatiramer Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Glatiramer Drugs Sales, 2017-2028
  6.4.3 US Glatiramer Drugs Market Size, 2017-2028
  6.4.4 Canada Glatiramer Drugs Market Size, 2017-2028
  6.4.5 Mexico Glatiramer Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Glatiramer Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Glatiramer Drugs Sales, 2017-2028
  6.5.3 Germany Glatiramer Drugs Market Size, 2017-2028
  6.5.4 France Glatiramer Drugs Market Size, 2017-2028
  6.5.5 U.K. Glatiramer Drugs Market Size, 2017-2028
  6.5.6 Italy Glatiramer Drugs Market Size, 2017-2028
  6.5.7 Russia Glatiramer Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Glatiramer Drugs Market Size, 2017-2028
  6.5.9 Benelux Glatiramer Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Glatiramer Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Glatiramer Drugs Sales, 2017-2028
  6.6.3 China Glatiramer Drugs Market Size, 2017-2028
  6.6.4 Japan Glatiramer Drugs Market Size, 2017-2028
  6.6.5 South Korea Glatiramer Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Glatiramer Drugs Market Size, 2017-2028
  6.6.7 India Glatiramer Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Glatiramer Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Glatiramer Drugs Sales, 2017-2028
  6.7.3 Brazil Glatiramer Drugs Market Size, 2017-2028
  6.7.4 Argentina Glatiramer Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Glatiramer Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Glatiramer Drugs Sales, 2017-2028
  6.8.3 Turkey Glatiramer Drugs Market Size, 2017-2028
  6.8.4 Israel Glatiramer Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Glatiramer Drugs Market Size, 2017-2028
  6.8.6 UAE Glatiramer Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Teva
  7.1.1 Teva Corporate Summary
  7.1.2 Teva Business Overview
  7.1.3 Teva Glatiramer Drugs Major Product Offerings
  7.1.4 Teva Glatiramer Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Teva Key News
7.2 NATCO Pharma
  7.2.1 NATCO Pharma Corporate Summary
  7.2.2 NATCO Pharma Business Overview
  7.2.3 NATCO Pharma Glatiramer Drugs Major Product Offerings
  7.2.4 NATCO Pharma Glatiramer Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 NATCO Pharma Key News
7.3 Mylan
  7.3.1 Mylan Corporate Summary
  7.3.2 Mylan Business Overview
  7.3.3 Mylan Glatiramer Drugs Major Product Offerings
  7.3.4 Mylan Glatiramer Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Mylan Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Glatiramer Drugs Major Product Offerings
  7.4.4 Novartis Glatiramer Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Novartis Key News
7.5 HYBIO
  7.5.1 HYBIO Corporate Summary
  7.5.2 HYBIO Business Overview
  7.5.3 HYBIO Glatiramer Drugs Major Product Offerings
  7.5.4 HYBIO Glatiramer Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 HYBIO Key News

8 GLOBAL GLATIRAMER DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Glatiramer Drugs Production Capacity, 2017-2028
8.2 Glatiramer Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Glatiramer Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 GLATIRAMER DRUGS SUPPLY CHAIN ANALYSIS

10.1 Glatiramer Drugs Industry Value Chain
10.2 Glatiramer Drugs Upstream Market
10.3 Glatiramer Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Glatiramer Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Glatiramer Drugs in Global Market
Table 2. Top Glatiramer Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Glatiramer Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Glatiramer Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Glatiramer Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Glatiramer Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Glatiramer Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Glatiramer Drugs Product Type
Table 9. List of Global Tier 1 Glatiramer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glatiramer Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Glatiramer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Glatiramer Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Glatiramer Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Glatiramer Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Glatiramer Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Glatiramer Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Glatiramer Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Glatiramer Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Glatiramer Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Glatiramer Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Glatiramer Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Glatiramer Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Glatiramer Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Glatiramer Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Glatiramer Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Glatiramer Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Glatiramer Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Glatiramer Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Glatiramer Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Glatiramer Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Glatiramer Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Glatiramer Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Glatiramer Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Glatiramer Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Glatiramer Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Glatiramer Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Glatiramer Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Glatiramer Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Glatiramer Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Glatiramer Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Glatiramer Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Glatiramer Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Glatiramer Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Glatiramer Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Glatiramer Drugs Sales, (K Units), 2023-2028
Table 46. Teva Corporate Summary
Table 47. Teva Glatiramer Drugs Product Offerings
Table 48. Teva Glatiramer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. NATCO Pharma Corporate Summary
Table 50. NATCO Pharma Glatiramer Drugs Product Offerings
Table 51. NATCO Pharma Glatiramer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Mylan Corporate Summary
Table 53. Mylan Glatiramer Drugs Product Offerings
Table 54. Mylan Glatiramer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Novartis Corporate Summary
Table 56. Novartis Glatiramer Drugs Product Offerings
Table 57. Novartis Glatiramer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. HYBIO Corporate Summary
Table 59. HYBIO Glatiramer Drugs Product Offerings
Table 60. HYBIO Glatiramer Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Glatiramer Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global Glatiramer Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Glatiramer Drugs Production by Region, 2017-2022 (K Units)
Table 64. Global Glatiramer Drugs Production by Region, 2023-2028 (K Units)
Table 65. Glatiramer Drugs Market Opportunities & Trends in Global Market
Table 66. Glatiramer Drugs Market Drivers in Global Market
Table 67. Glatiramer Drugs Market Restraints in Global Market
Table 68. Glatiramer Drugs Raw Materials
Table 69. Glatiramer Drugs Raw Materials Suppliers in Global Market
Table 70. Typical Glatiramer Drugs Downstream
Table 71. Glatiramer Drugs Downstream Clients in Global Market
Table 72. Glatiramer Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Glatiramer Drugs Segment by Type
Figure 2. Glatiramer Drugs Segment by Application
Figure 3. Global Glatiramer Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Glatiramer Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glatiramer Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Glatiramer Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Glatiramer Drugs Revenue in 2021
Figure 9. By Type - Global Glatiramer Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Glatiramer Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Glatiramer Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Glatiramer Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Glatiramer Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Glatiramer Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Glatiramer Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Glatiramer Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Glatiramer Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Glatiramer Drugs Sales Market Share, 2017-2028
Figure 19. US Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Glatiramer Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Glatiramer Drugs Sales Market Share, 2017-2028
Figure 24. Germany Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Glatiramer Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Glatiramer Drugs Sales Market Share, 2017-2028
Figure 33. China Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Glatiramer Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Glatiramer Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Glatiramer Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Glatiramer Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Glatiramer Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Glatiramer Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Glatiramer Drugs by Region, 2021 VS 2028
Figure 50. Glatiramer Drugs Industry Value Chain
Figure 51. Marketing Channels